ZA200707413B - Cat allergen fusion proteins and uses thereof - Google Patents
Cat allergen fusion proteins and uses thereofInfo
- Publication number
- ZA200707413B ZA200707413B ZA200707413A ZA200707413A ZA200707413B ZA 200707413 B ZA200707413 B ZA 200707413B ZA 200707413 A ZA200707413 A ZA 200707413A ZA 200707413 A ZA200707413 A ZA 200707413A ZA 200707413 B ZA200707413 B ZA 200707413B
- Authority
- ZA
- South Africa
- Prior art keywords
- fusion proteins
- cat allergen
- allergen fusion
- cat
- proteins
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66291805P | 2005-03-18 | 2005-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707413B true ZA200707413B (en) | 2009-01-28 |
Family
ID=36843236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707413A ZA200707413B (en) | 2005-03-18 | 2006-03-17 | Cat allergen fusion proteins and uses thereof |
Country Status (19)
Country | Link |
---|---|
US (3) | US7767212B2 (fr) |
EP (1) | EP1868642B1 (fr) |
JP (2) | JP5302671B2 (fr) |
KR (1) | KR20070112225A (fr) |
CN (2) | CN101141979B (fr) |
AU (1) | AU2006224529B2 (fr) |
BR (1) | BRPI0608455A2 (fr) |
CA (1) | CA2599218C (fr) |
CY (1) | CY1114171T1 (fr) |
DK (1) | DK1868642T3 (fr) |
ES (1) | ES2424229T3 (fr) |
IL (1) | IL185103A0 (fr) |
MX (1) | MX2007011160A (fr) |
NZ (1) | NZ561040A (fr) |
PL (1) | PL1868642T3 (fr) |
PT (1) | PT1868642E (fr) |
RU (1) | RU2414239C2 (fr) |
WO (1) | WO2006097530A2 (fr) |
ZA (1) | ZA200707413B (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7320793B2 (en) * | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
EP1450856B1 (fr) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | Emballage de cpg dans des particules de type virus : procede de preparation et utilisation correspondante |
CN102061288A (zh) * | 2002-07-17 | 2011-05-18 | 希托斯生物技术股份公司 | 使用衍生自ap205外壳蛋白的病毒样颗粒的分子抗原阵列 |
SI1524994T1 (sl) * | 2002-07-19 | 2011-08-31 | Cytos Biotechnology Ag | Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe |
EP1868642B1 (fr) * | 2005-03-18 | 2013-05-08 | Cytos Biotechnology AG | Conjugues d'allergene du chat et utilisations associees |
AU2006325225B2 (en) * | 2005-12-14 | 2013-07-04 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
WO2007113633A2 (fr) * | 2006-04-03 | 2007-10-11 | Pfizer Products Inc. | Traitement allergène contre les poils et squames de chat |
AT503690A1 (de) * | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
MX2008015529A (es) | 2006-06-12 | 2009-01-13 | Cytos Biotechnology Ag | Procesos para empacar oligonucleotidos en particulas similares a virus de bacteriofagos de arn. |
ES2618885T3 (es) | 2006-09-29 | 2017-06-22 | Takeda Vaccines, Inc. | Formulaciones de vacuna para norovirus |
US9388236B2 (en) | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
PL2162133T3 (pl) * | 2007-07-09 | 2017-03-31 | Nestec S.A. | Sposoby zmniejszania alergii wywoływanych przez alergeny środowiskowe |
KR20100083150A (ko) | 2007-09-18 | 2010-07-21 | 리고사이트 파머슈티컬즈 인코퍼레이티드 | 노로바이러스에 대한 보호면역반응을 제공하는 방법 |
US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
EP2042193A1 (fr) * | 2007-09-28 | 2009-04-01 | Biomay AG | Vaccins RNA |
JP5852883B2 (ja) | 2008-08-08 | 2016-02-03 | タケダ ワクチン,インコーポレイテッド | 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 |
GB2498323B8 (en) * | 2009-11-05 | 2014-08-06 | Hal Padgett | Generation of antigenic virus-like particles through protein-protein linkages |
US8321012B2 (en) * | 2009-12-22 | 2012-11-27 | The Invention Science Fund I, Llc | Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
BR112014000656A2 (pt) | 2011-07-11 | 2017-02-14 | Takeda Vaccines Inc | formulações de vacina parenteral contra norovírus |
CN104011080B (zh) | 2011-12-22 | 2017-10-20 | 弗·哈夫曼-拉罗切有限公司 | 用于真核细胞的全长抗体展示系统及其用途 |
JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
EP3587455A1 (fr) * | 2012-10-23 | 2020-01-01 | Emory University | Conjugués de gm-csf et d'il-4, compositions et procédés associés |
US10935554B2 (en) | 2013-08-23 | 2021-03-02 | Regeneron Pharmaceuticals, Inc. | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) |
WO2015092663A1 (fr) * | 2013-12-19 | 2015-06-25 | Nestec Sa | Compositions et méthodes pour réduire les allergènes félins dans l'environnement |
MA40824A (fr) | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
WO2016112921A1 (fr) | 2015-01-15 | 2016-07-21 | University Of Copenhagen | Pseudo-particule virale à présentation efficace des épitopes |
WO2016192788A1 (fr) * | 2015-06-03 | 2016-12-08 | Universität Zürich Prorektorat Mnw | Procédés et compositions pour prévenir et traiter une allergie aux phanères de chat ou de chien |
RU2018105007A (ru) | 2015-09-08 | 2019-10-10 | Университет Цюрих | Композиции против аллергии на кошек |
ES2854726T3 (es) | 2015-10-30 | 2021-09-22 | The Univ Of Copenhagen | Partícula similar a virus con presentación eficiente de epítopos |
CN105219742A (zh) * | 2015-11-10 | 2016-01-06 | 海南大学 | 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用 |
WO2017179025A1 (fr) | 2016-04-15 | 2017-10-19 | Alk-Abelló A/S | Polypeptides épitopiques d'allergènes de pollen d'ambroisie |
FR3054547B1 (fr) * | 2016-07-29 | 2020-06-05 | Angany Inc. | Particules pseudo-virales et leurs utilisations |
US11352417B2 (en) | 2016-12-22 | 2022-06-07 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
AU2019406749A1 (en) | 2018-12-20 | 2021-05-27 | Saiba AG | Virus-like particles of CMV modified by fusion |
WO2023176206A1 (fr) * | 2022-03-18 | 2023-09-21 | デンカ株式会社 | Particule de type viral contenant des protéines de capside reliées par un lieur |
CN114933639B (zh) * | 2022-05-05 | 2023-12-29 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途 |
CN117004650B (zh) * | 2023-06-25 | 2024-05-14 | 山东立菲生物产业有限公司 | 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4163778A (en) * | 1978-05-04 | 1979-08-07 | The Foundation for the Study of Asthma and Related Diseases | Asthma immunotherapy |
US5374426A (en) | 1986-09-03 | 1994-12-20 | University Of Saskatchewan | Rotavirus nucleocapsid protein VP6 in vaccine compositions |
ATE130197T1 (de) | 1988-06-14 | 1995-12-15 | Cell Med Inc | Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren. |
US6120769A (en) | 1989-11-03 | 2000-09-19 | Immulogic Pharmaceutical Corporation | Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
EP0563091A1 (fr) | 1990-12-20 | 1993-10-06 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | VACCINS A BASE DE l'ANTIGENE D'ENVELOPPE DU VIRUS DE L'HEPATITE B |
GB9114003D0 (en) | 1991-06-28 | 1991-08-14 | Mastico Robert A | Chimaeric protein |
GB9213601D0 (en) | 1992-06-26 | 1992-08-12 | Mastico Robert A | Protein based delivery system |
WO1996007428A1 (fr) | 1994-09-02 | 1996-03-14 | Immulogic Pharmaceutical Corporation | Compositions peptidiques pouvant reguler a la baisse une reponse immunitaire specifique a un antigene |
US6759234B1 (en) | 1994-09-02 | 2004-07-06 | Immulogic Pharmaceutical Corporation | Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
EP0817854A2 (fr) | 1995-03-31 | 1998-01-14 | Wolf, Hans, Prof. Dr. | Systeme de presentation d'antigenes fonde sur des particules similaires a des retrovirus |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
US6054312A (en) | 1997-08-29 | 2000-04-25 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
WO1999030736A2 (fr) | 1997-12-16 | 1999-06-24 | Regents Of The University Of Minnesota | Procedes permettant de traiter des reponses immunitaires indesirables |
AR020102A1 (es) | 1998-07-30 | 2002-04-10 | Ucb Sa | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento |
WO2000020032A1 (fr) | 1998-10-06 | 2000-04-13 | Trustees Of Dartmouth College | ALLERGENE RECOMBINANT DU CHAT, Fel dI, EXPRIMES DANS BACULOVIRUS POUR DIAGNOSTIQUER OU TRAITER L'ALLERGIE AUX CHATS |
EP1123114B1 (fr) | 1998-10-21 | 2005-12-28 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Particules assimilees a des virus pour l'induction d'auto-anticorps |
MXPA01005389A (es) * | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
AP1775A (en) | 1999-09-25 | 2007-08-28 | Univ Iowa Res Found | Immunostimulatory nucleic acids. |
WO2001085208A2 (fr) | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Jeu ordonne d'antigenes moleculaires |
KR100919914B1 (ko) | 2000-11-16 | 2009-10-06 | 알크-아벨로 에이/에스 | 신규한 돌연변이체 알레르겐 |
EP1221317A1 (fr) | 2000-12-28 | 2002-07-10 | SHAN-Beteiligungsgesellschaft m.b.H. | Vaccins comprenant des polypeptides hybrides constitué d'au moins deux allergènes différents |
EP1219300B1 (fr) | 2000-12-28 | 2006-12-06 | BIOMAY Produktions- und Handels- Aktiengesellschaft | Traitement des allergies |
US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
JP2005508134A (ja) | 2001-03-02 | 2005-03-31 | ザ ロックフェラー ユニヴァーシティ | 天然アレルゲンの免疫原性を保持する、アレルゲン性が低下した組み換えハイブリッドアレルゲン構築体 |
EP1450856B1 (fr) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | Emballage de cpg dans des particules de type virus : procede de preparation et utilisation correspondante |
AU2002347404A1 (en) | 2001-09-14 | 2003-04-01 | Cytos Biotechnology Ag | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
DK1443960T3 (da) * | 2001-11-07 | 2009-03-23 | Cytos Biotechnology Ag | Antigen-arrays der betegner IL-5, IL-13 eller eotaxin til behandling af allergiske eosinofile sygdomme |
BR0213941A (pt) * | 2001-11-07 | 2004-08-31 | Cytos Biotechnology Ag | Arranjos de antìgeno para o tratamento de doença óssea |
CN102061288A (zh) | 2002-07-17 | 2011-05-18 | 希托斯生物技术股份公司 | 使用衍生自ap205外壳蛋白的病毒样颗粒的分子抗原阵列 |
PL375522A1 (en) | 2002-07-19 | 2005-11-28 | Cytos Biotechnology Ag | Ghrelin-carrier conjugates |
US20060251620A1 (en) | 2002-08-22 | 2006-11-09 | Lidia Ivanova | Inducible alphaviral/orip based gene expression system |
JP2006520184A (ja) | 2002-11-01 | 2006-09-07 | アルカベロ アクチェセルスカプ | 組換えタンパク質変種 |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
AU2004224762B2 (en) * | 2003-03-26 | 2009-12-24 | Kuros Us Llc | Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
US20090117136A1 (en) | 2003-04-24 | 2009-05-07 | Imvision Gmbh | Recombinant allergen |
CN100404070C (zh) * | 2003-07-10 | 2008-07-23 | 赛托斯生物技术公司 | 包装的病毒样颗粒 |
EP1868642B1 (fr) * | 2005-03-18 | 2013-05-08 | Cytos Biotechnology AG | Conjugues d'allergene du chat et utilisations associees |
-
2006
- 2006-03-17 EP EP06725140.5A patent/EP1868642B1/fr not_active Not-in-force
- 2006-03-17 ES ES06725140T patent/ES2424229T3/es active Active
- 2006-03-17 JP JP2008501331A patent/JP5302671B2/ja not_active Expired - Fee Related
- 2006-03-17 CN CN2006800088726A patent/CN101141979B/zh not_active Expired - Fee Related
- 2006-03-17 KR KR1020077022225A patent/KR20070112225A/ko not_active Application Discontinuation
- 2006-03-17 PT PT67251405T patent/PT1868642E/pt unknown
- 2006-03-17 US US11/886,577 patent/US7767212B2/en not_active Expired - Fee Related
- 2006-03-17 ZA ZA200707413A patent/ZA200707413B/xx unknown
- 2006-03-17 NZ NZ561040A patent/NZ561040A/en not_active IP Right Cessation
- 2006-03-17 BR BRPI0608455-9A patent/BRPI0608455A2/pt active Search and Examination
- 2006-03-17 AU AU2006224529A patent/AU2006224529B2/en not_active Ceased
- 2006-03-17 CN CN2013101152149A patent/CN103203016A/zh active Pending
- 2006-03-17 RU RU2007138265/15A patent/RU2414239C2/ru not_active IP Right Cessation
- 2006-03-17 PL PL06725140T patent/PL1868642T3/pl unknown
- 2006-03-17 DK DK06725140.5T patent/DK1868642T3/da active
- 2006-03-17 WO PCT/EP2006/060845 patent/WO2006097530A2/fr active Application Filing
- 2006-03-17 MX MX2007011160A patent/MX2007011160A/es active IP Right Grant
- 2006-03-17 CA CA2599218A patent/CA2599218C/fr not_active Expired - Fee Related
-
2007
- 2007-08-07 IL IL185103A patent/IL185103A0/en not_active IP Right Cessation
-
2010
- 2010-05-21 US US12/785,174 patent/US20110045013A1/en not_active Abandoned
-
2012
- 2012-12-21 US US13/724,331 patent/US20130344098A1/en not_active Abandoned
-
2013
- 2013-03-12 JP JP2013048847A patent/JP2013155176A/ja active Pending
- 2013-07-26 CY CY20131100638T patent/CY1114171T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006097530A3 (fr) | 2007-06-21 |
CY1114171T1 (el) | 2016-08-31 |
NZ561040A (en) | 2009-04-30 |
CA2599218A1 (fr) | 2006-09-21 |
CN103203016A (zh) | 2013-07-17 |
US20130344098A1 (en) | 2013-12-26 |
KR20070112225A (ko) | 2007-11-22 |
JP5302671B2 (ja) | 2013-10-02 |
AU2006224529A1 (en) | 2006-09-21 |
CN101141979B (zh) | 2013-05-08 |
PT1868642E (pt) | 2013-07-10 |
MX2007011160A (es) | 2007-11-13 |
RU2007138265A (ru) | 2009-04-27 |
BRPI0608455A2 (pt) | 2010-01-05 |
US7767212B2 (en) | 2010-08-03 |
DK1868642T3 (da) | 2013-06-24 |
JP2008535800A (ja) | 2008-09-04 |
JP2013155176A (ja) | 2013-08-15 |
IL185103A0 (en) | 2007-12-03 |
WO2006097530A2 (fr) | 2006-09-21 |
US20090175896A1 (en) | 2009-07-09 |
EP1868642B1 (fr) | 2013-05-08 |
RU2414239C2 (ru) | 2011-03-20 |
EP1868642A2 (fr) | 2007-12-26 |
US20110045013A1 (en) | 2011-02-24 |
CN101141979A (zh) | 2008-03-12 |
ES2424229T3 (es) | 2013-09-30 |
AU2006224529B2 (en) | 2012-05-24 |
CA2599218C (fr) | 2015-08-11 |
PL1868642T3 (pl) | 2013-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200707413B (en) | Cat allergen fusion proteins and uses thereof | |
IL235620A0 (en) | sp35 antibodies and their uses | |
IL222922A (en) | Antibodies against neurophilin-1 and their use | |
PL1830872T3 (pl) | Białka fuzyjne | |
GB0426397D0 (en) | Fusion proteins | |
IL189246A0 (en) | Albumin fusion proteins | |
PT2650020T (pt) | Proteína de fusão de imunoglobulina ox-40 trimérica e métodos do campo de utilização | |
AP2008004471A0 (en) | Anti-Alpha2 Intergin antibodies and their uses | |
EP2007884A4 (fr) | Proteines de fusion enzymatiques et leur utilisation | |
EP1934372A4 (fr) | Proteines hybrides ssb-polymerase | |
IL184024A0 (en) | Irta-5 antibodies and their uses | |
EP1960523A4 (fr) | Proteines toxines formatrices de pores modifiees et leurs utilisations | |
ZA200801224B (en) | Albumin fusion proteins | |
EP1904845A4 (fr) | Résultats et application améliorés d'épreuves de comparaison d'expressions protéiniques | |
EP1878801A4 (fr) | Procede de clivage de proteine et son utilisation | |
GB0513878D0 (en) | Cat allergen | |
EP1877425A4 (fr) | Proteines fluorescentes et leurs utilisations | |
SI1868642T1 (sl) | Mačji alergen-fuzijski proteini in njihove uporabe | |
ZA200808656B (en) | Enzyme fusion proteins and their use | |
GB0417390D0 (en) | Chimeric proteins and uses thereof | |
IL179998A0 (en) | Chimeric proteins and uses thereof | |
HK1082770A1 (en) | Supter-antigen fusion proteins and the use thereof | |
GB0426399D0 (en) | Fusion proteins | |
AU2004901156A0 (en) | Cat allergen | |
AU2004902079A0 (en) | Cat allergen |